Addiction Treatment

Addiction is a brain disease with strong neurobiological underpinnings. Dr. DiFrancesco provides evidence-based pharmacological treatment for substance use disorders, including emerging approaches using GLP-1 receptor agonists that show remarkable promise.

Conditions Addressed

• Alcohol Use Disorder — including detoxification support and relapse prevention
• Nicotine Dependence — pharmacological cessation support
• Opioid Use Disorder — medication-assisted treatment
• Stimulant Use Disorder — cocaine and amphetamine dependence
• Cannabis Use Disorder

Treatment Approach

Treatment combines evidence-based pharmacotherapy with psychiatric assessment and coordination with addiction counselors. Dr. DiFrancesco is particularly interested in emerging GLP-1 receptor agonists (e.g., semaglutide) that show early promise in reducing cravings across multiple substance use disorders.